PFIZER LTD.

NSE : PFIZERBSE : 500680ISIN CODE : INE182A01018Industry : Pharmaceuticals & DrugsHouse : Pfizer - MNC
BSE4115.0513.4 (+0.33 %)
PREV CLOSE ( ) 4101.65
OPEN PRICE ( ) 4050.10
BID PRICE (QTY) 4108.75 (4)
OFFER PRICE (QTY) 4118.55 (4)
VOLUME 351
TODAY'S LOW / HIGH ( )4050.10 4136.50
52 WK LOW / HIGH ( )3672.65 4940
NSE4118.5010.65 (+0.26 %)
PREV CLOSE( ) 4107.85
OPEN PRICE ( ) 4111.45
BID PRICE (QTY) 4114.50 (2)
OFFER PRICE (QTY) 4118.50 (8)
VOLUME 10987
TODAY'S LOW / HIGH( ) 4085.00 4141.90
52 WK LOW / HIGH ( )3656 5000
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 21-11 1950
Management Info
Pradip Shah - Chairman Meenakshi Nevatia - Managing Director
Registered Office

Address The Capital, 1802/1901,Plot No. C-70, G Block,Bandra Kurla Complex, Bandra (East),
Mumbai,
Maharashtra-400051

Phone 022 6693 2000

Email contactus.india@pfizer.com

Website www.pfizerltd.co.in

Registrars Details
K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, MCX
NEWS
12Apr Intimation Regarding Appointment Of C
Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, we hereby in..
22Jan Pfizer informs about appointment of ex
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosur..
18Aug Pfizer informs about change in managem
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Re..
20Jul Pfizer informs about loss of share cer
Pursuant to Regulation 39 (3) and other applicable regulations of SEBI (..
20Jun Pfizer informs about loss of share cer
Pursuant to Regulation 39 (3) and other applicable regulations of SEBI (..
Financials
Rs. in Millions
QTR Dec 23 ANNUAL 23
Net Profit1299.86239.3
Gross Profit 1759.4 8240.1
Operating Profit 18849099.1
Net Sales 5399.724247.6
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Neuland Laboratories (BSE)
 7477.45 (5.24%)
M.Cap (Rs. in Cr)9508.49
NGL Fine-Chem (BSE)
 2228.65 (4.30%)
M.Cap (Rs. in Cr)1377.33
Astrazeneca Pharma I (BSE)
 5283.95 (1.76%)
M.Cap (Rs. in Cr)13106.75
Abbott India (BSE)
 26275.00 (0.33%)
M.Cap (Rs. in Cr)55742.76
Alkem Laboratories (BSE)
 4762.85 (1.15%)
M.Cap (Rs. in Cr)56826.26
Shareholding Pattern
PROMOTERS 63.92%
NON-INSTITUTION 17.9%
MUTUAL FUNDS/UTI 7.61%
FI/BANKS/INSURANCE 7.54%
GOVERNMENT 0%
FII 0%
ATTENTION INVESTORSKYCIPO
Download Client Registration Documents (Rights & Obligations, Risk Disclosure Document, Do’s & Don’t’s) in Vernacular Language :
REGISTRATION NOS.

NSE CM-INZ000234235|NSE F& O - INZ000234235, NSE CD-INZ000234235, BSE CM–INZ000234235 |BSE F & O - INZ000234235|BSE CD- INZ000234235 MCX-SX CM-INZ000234235|MCX-SX F & O - INZ000234235|MCX-SX CD-INZ000234235 NSDL - IN-DP-NSDL-319-2009ROC REG - 21-097912,CDSL : IN-DP-242-2016|SEBI-PMS: INP000007100|LEI- 3358007DLCFNHY8J2F96

Filing compliant on SCORES – Easy & quick

  • Register on SCORES portal
  • Mandatory details for filing complaints on SCORES:
    • Name
    • PAN
    • Address
    • Mobile Number
    • E-mail ID
  • Benefits:
    • i.) Effective communication
    • ii.) Speedy redressal of the grievances
INVESTOR PROTECTION

Compliance officer : Apurva Mittal, Tel No: 022-40790035,022-40790024, Mobile No: 9152943075, E-mail ID: compliance@nnmsecurities.com, cdsl@nnmsecurities.com

Investor grievance : support@nnmsecurities.com

"NNM Securities has partnered with TradingView for its charting technology. An investment and trading platform empowering users with global market data and analytical tools like Stock Screener and Economic Calendar."

Copyright © 2021 NNM Securities.com

Advanced Charts Technology Partner: TradingView

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.